Department of Biostatistics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Biostatistics, School of Public Health, Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
J Gastrointest Cancer. 2022 Sep;53(3):614-622. doi: 10.1007/s12029-021-00677-z. Epub 2021 Aug 4.
Since cancer patients are at higher risk of COVID-19, the present study was conducted to investigate the epidemiology of these patients and identify the affecting risk factors on their mortality.
The present retrospective cohort study was conducted on 66 hospitalized patients with cancer and COVID-19 in Hamadan in 2020. In the present study, demographic, clinical, and laboratory information and patients' outcome were collected through a checklist and its impact on death was assessed. Data were analyzed in SPSS-24 software and the significance level of the tests was considered at 5%.
The mean (standard deviation (SD)) age of patients was 61.6 (13.5) years. Forty patients (60.6%) were male. Twenty and five patients (37.9%) died at the end of study. The results of logistic regression model revealed that the nausea, mechanical ventilation, admission to ICU, and length of hospital stay in the ward had a significant impact on the odds of death among cancer patients with COVID-19 (p < 0.05).
Owing to high mortality rate in cancer patients with COVID-19 and due to underlying diseases and more severe clinical symptoms than other patients with coronavirus, these patients need intensive care and specific treatments. However, screening these patients and early identifying and vaccinating of them can reduce the mortality rate in these patients.
由于癌症患者患 COVID-19 的风险较高,本研究旨在调查这些患者的流行病学情况,并确定影响其死亡率的相关危险因素。
本回顾性队列研究于 2020 年在伊朗哈马丹对 66 例住院的癌症合并 COVID-19 患者进行。本研究通过检查表收集了患者的人口统计学、临床和实验室信息以及患者的结局,并评估了其对死亡的影响。数据采用 SPSS-24 软件进行分析,检验的显著性水平设为 5%。
患者的平均(标准差)年龄为 61.6(13.5)岁。40 名患者(60.6%)为男性。25 名患者(37.9%)在研究结束时死亡。逻辑回归模型的结果表明,癌症合并 COVID-19 患者中恶心、机械通气、入住 ICU 和住院时间对死亡的可能性有显著影响(p<0.05)。
由于 COVID-19 合并癌症患者的死亡率较高,且与其他冠状病毒患者相比,这些患者存在基础疾病和更严重的临床症状,因此需要加强护理和特殊治疗。然而,对这些患者进行筛查,早期识别和接种疫苗可以降低这些患者的死亡率。